| 孟鲁斯特治疗支气管哮喘的临床观察 |
| |
| 引用本文： | 罗艺,张浒.孟鲁斯特治疗支气管哮喘的临床观察[J].中国医药导报,2011,8(16):87-87. |
| |
| 作者姓名： | 罗艺 张浒 |
| |
| 作者单位： | 广东省高州市中医院内科,广东高州,525200 |
| |
| 摘 要： | 目的：观察孟鲁斯特对支气管哮喘的疗效。方法：将40例支气管哮喘患者随机分为治疗组和对照组,各40例,治疗组在对照组的基础上应用孟鲁斯特10 mg/d,对照组予吸入糖皮质激素（ICS）布地奈德喷雾剂和长效β2受体激动剂（LABA）福莫特罗喷雾剂,急性严重发作时加用速效吸入β2受体激动剂和吸氧治疗。比较两组哮喘缓解情况和发作的频率及总有效率。结果：治疗组总有效率为90.0%（36/40例）高于对照组85.0%（34/40例）,差异有统计学意义（P〈0.05）。结论：孟鲁斯特对支气管哮喘的疗效显著,安全性好,值得推广应用。
|
| 关 键 词： | 孟鲁斯特 支气管哮喘 临床疗效 |
Clinical observation of bronchial asthma treated by Montelukast |
| |
| LUO Yi,ZHANG Hu.Clinical observation of bronchial asthma treated by Montelukast[J].China Medical Herald,2011,8(16):87-87. |
| |
| Authors: | LUO Yi ZHANG Hu |
| |
| Institution: | LUO Yi,ZHANG Hu Department of Medicine,Traditional Chinese Medicine Hospital of Gaozhou City,Guangdong Province,Gaozhou 525200,China |
| |
| Abstract: | Objective： To observe the long-term therapeutic effect of Montelukast on bronchial asthma.Methods： Forty patients with bronchial asthma were enrolled and divided into treatment group and control group randomly.The patients in control group were treated with inhaled corticosteroid（ICS）（10 mg/d） and long acting β2-agonist（LABA）,and those in treatment group were added Montelukast.Both of the groups were inhaled short-acting β2-agonists and given oxygen therapy.Results： The effective rate of treatment group was higher than that of control group（90.0% vs 85.0%,P0.05）.Conclusion： Montelukast is an effective and safe treatment method to bronchial asthma and worthy to clinical application. |
| |
| Keywords: | Montelukast Bronchial asthma Clinical efficacy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
